FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 52 filers reported holding FINCH THERAPEUTICS GROUP INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,620 | -59.1% | 24,479 | -50.0% | 0.00% | – |
| Q4 2022 | $23,500 | -42.7% | 48,958 | +100.0% | 0.00% | – |
| Q3 2022 | $41,000 | -41.4% | 24,479 | 0.0% | 0.00% | – |
| Q2 2022 | $70,000 | -87.2% | 24,479 | -77.6% | 0.00% | – |
| Q1 2022 | $549,000 | -48.2% | 109,194 | +2.8% | 0.00% | – |
| Q4 2021 | $1,059,000 | -22.0% | 106,219 | +1.7% | 0.00% | – |
| Q3 2021 | $1,357,000 | +35.8% | 104,412 | +47.0% | 0.00% | – |
| Q2 2021 | $999,000 | – | 71,018 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |